A new second-generation supraglottic airway device (Ambu(®) AuraGain(•)) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial

BACKGROUND AND AIMS: The Ambu(®) AuraGain(•) is a new single-use supraglottic airway device with gastric channel, designed to facilitate intubation. The study aimed to assess the success rates of proper placement and intubation using Ambu(®) AuraGain(•) compared with intubating laryngeal mask airway...

Descripción completa

Detalles Bibliográficos
Autores principales: Sudheesh, K, Chethana, GM, Chaithali, H, Nethra, SS, Devikarani, D, Shwetha, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644201/
https://www.ncbi.nlm.nih.gov/pubmed/31391619
http://dx.doi.org/10.4103/ija.IJA_269_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644201/
https://www.ncbi.nlm.nih.gov/pubmed/31391619
http://dx.doi.org/10.4103/ija.IJA_269_19

Ejemplares similares